Clinical Benefits of Sodium–Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects-Reference-Cited by-同舟云学术

Clinical Benefits of Sodium–Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects

Published:2022-06 Issue:3 Volume:2 Page:287-293
ISSN:2772-3747
Container-title:JACC: Asia
language:en
Short-container-title:JACC: Asia

Author:

Kubota Yoshiaki^ORCID,Shimizu Wataru

Publisher

Elsevier BV

Reference78 articles.

1. The war against heart failure: the Lancet lecture;Braunwald;Lancet,2015

2. Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the Heart and Soul Study;van Melle;Diabetes Care,2010

3. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology;Seferović;Eur J Heart Fail,2018

4. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America;Dunlay;Circulation,2019

5. Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get With The Guidelines-Heart Failure registry;Echouffo-Tcheugui;Am Heart J,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of ipragliflozin on left ventricular diastolic function in patients with type 2 diabetes: A sub-analysis of the PROTECT trial;J CARDIOL;2024

2. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

3. Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan–Meier Curves with Trial Sequential Analysis;American Journal of Cardiovascular Drugs;2024-07-04

4. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review;International Journal of Molecular Sciences;2024-06-27

5. New Perspectives in Management of Cardiovascular Risk Among People With Diabetes;Journal of the American Heart Association;2024-06-18